ArticleJournal of family medicine and primary care2026
Distribution and prevalence of HPV in HIV-negative and -positive women: Hospital-based study from Central India.
Article in Journal of family medicine and primary care, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Causal association of human papillomavirus (HPV) with genital malignancies and nonmalignant disorders is well established. Immunocompromised status can affect the prevalence of HPV infection and presentation. Aims and Objectives: The aim of this study was to look at the prevalence of HPV strains in human immunodeficiency virus (HIV)-negative and -positive women, to plan screening strategies and identify high-risk women early for early cancer prevention. Materials and Methods: A total of 1095 women screened for HPV were analyzed retrospectively. Available details were entered in the master chart, and descriptive analysis was done. Results: Three hundred forty-five HIV-negative and 750 HIV-positive women were screened. The HPV positivity rate was 11.8% in the HIV-negative group, while it was 31.6% in HIV-positive women. Discussion and Conclusion: This study highlights the increased risk of HPV infection and cervical dysplasia in HIV-positive women, stressing the need for comprehensive cervical cancer screening. Regular HPV and triage testing are vital for early detection and cancer prevention. Implementing one-stop solutions at anti retroviral therapy (ART) centers, including counseling, ART management, and cervical cancer screening, will improve outcomes. Enhanced public health initiatives for HPV vaccination and routine screening are essential for reducing cervical cancer burden in high-risk groups.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.